News

Pharmac is seeking feedback on a proposal to widen access to three funded medicines for people with type 2 diabetes.Under the proposal, access to empagliflozin, liraglutide and dulaglutide would be widened so more people at high clinical risk can access these medicines earlier in their treatment. The proposal aims to support better long‑term management of diabetes and reduce the risk of serious heart and kidney complications.We are now inviting feedback on this proposal....

Residential Eldercare Services have been working with, and have been owned and operated by Nurse Practitioners and General Practitioners for the last 14 years in the Waikato. We work in a supportive group manner covering all aspects of eldercare, general medical care and palliative care throughout the Waikato area. We are looking for another Nurse Practitioner or Nurse Practitioner Intern to join our growing practice. We have extensive experience in taking Nurse Practitioners through their...

This link will take you to the notification of the decision to award Principal Supply Status for permanent coronary drug-eluting stents (DES) to Medtronic New Zealand Limited (“Medtronic”) Medtronic’s Resolute Onyx DES will be listed on the Pharmaceutical Schedule and available for Health NZ hospitals at a reduced price from 1 June 2026. If you need any further information please visit our website. Ngā mihi Mikka Nocete | Device Category Manager ______________________________________________...

Kaiwhakamahereora | Counsellor, Outreach Can you offer support to people from a range of backgrounds and cultures? Have you got experience providing phone counselling, nursing triage, or holistic need assessment? Do you have a completed (or nearly completed) tertiary qualification in counselling, nursing, social work, or a related field? Kōrero mō te tūranga - About the role Te Herenga Waka - Victoria University of Wellington is currently recruiting a Kaiwhakamahereora - Counsellor,...

Pharmac is reviewing how it funds medicines for people with exceptional clinical circumstances (including the Named Patient Pharmaceutical Assessment - NPPA), and we want to hear from you. We’ve heard that the current Exceptional Circumstances Framework can be difficult to understand and doesn’t always work as well as it should. This review is an opportunity to improve how the framework operates, and your feedback is important. Nothing will change during the review - applications will...

Please find attached a memo outlining the rationale and clinical use of the above combination in adult patients. This has been developed by the Health NZ Antimicrobial Stewardship Working Group in partnership with the Te Whata Kura Development Team. We encourage you to share this information widely across your networks. Ngā mihi nui, Sharon Gardiner(on behalf of the Health NZ Antimicrobial Stewardship Working Group and the Te Whata Kura Development Team) Sharon Gardiner FPS, MClinPharm, PhD...